Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 5,341-5,352 of 6,115
Behavioral study icon
Not recruitingISRCTN10555820

The impact of digital mental health technology on mental health, education, and economic outlook of young adults

This study is looking at whether cognitive behavioural therapy can help people with Mild, moderate or severe symptoms of depression, anxiety or PTSD or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In Colombia
Why is this study shown?

This study includes Depression among several conditions.

PTSD, Depression, ...OtherFrom 18 Years to 100 Years
Countries
Colombia
Sponsor
Centre universitaire de médecine générale et santé publique, Lausanne
Condition
PTSD, Depression, ...
Other study type icon
Not recruitingISRCTN47575326

The Mellow Babies study

This study is looking at whether a parenting support programme can help people with Mothers who are having difficulties in their relationship with their baby. Mothers’ feelings of wellbeing, and the way mothers interact with their baby or Other.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherFrom 18 Years to 52 Years
Countries
United Kingdom
Sponsor
University of Aberdeen
Condition
Anxiety, Depression
Behavioral study icon
Not recruitingISRCTN55206395

The Newcastle COPD CBT CARE Study

This study is looking at whether cognitive behavioural therapy can help people with Anxiety, depression, respiratory or Mental and Behavioural Disorders. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
National Institute of Health Research (UK)
Condition
Anxiety, Depression
Behavioral study icon
Not recruitingISRCTN21184717

Wellbeing in children with neurological conditions

This study is looking at whether questionnaires and follow-up can help people with Mental health disorders in children and young people with neurological conditions, Mental and Behavioural Disorders, or Anxiety. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherFrom 7 Years to 18 Years
Countries
United Kingdom
Sponsor
Great Ormond Street Hospital for Children NHS Foundation Trust
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2006-001475-38

A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrugA study involving a medication or substance.
Countries
Netherlands
Sponsor
Janssen Cliag Ltd. C/O Johnson & Johnson PRD
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2006-003659-19

A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiet...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
United Kingdom
Sponsor
Janssen-Cilag International N.V.
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2018-002669-20

A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subjects with treatment-resistant bipolar depre...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Poland
Sponsor
Celon Pharma SA
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2018-002749-12

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients with Major D...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Bulgaria
Sponsor
Intra-Cellular Therapies, Inc. (ITI)
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2016-000756-98

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipo...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Bulgaria, Croatia, Slovakia
Sponsor
Forest Laboratories LLC, an Allergan Affiliate
Condition
Bipolarity, Depression
Drug study icon
Active Not RecruitingEUCTR 2021-003676-13

A prospective randomized, double blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital anesthesia for electroconvulsive therapy

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Vienna
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2017-003112-39

A Randomised Double-Blinded Placebo-Controlled Trial to Assess the Efficacy and Safety of Scopolamine Compared to Placebo in Individuals with Bipolarity who are Experiencing a Depressive Epis...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Ireland
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Ireland
Sponsor
National University of ireland Galway
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2013-000426-62

A randomized, double blind, placebo-controlled crossover study to investigate the effects of a selective serotonergic reuptake inhibitor on resting state fMRI in healthy volunteers.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDrug
Countries
Netherlands
Sponsor
Centre for Human Drug Research
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.